Nutrition / Drugs for Osteoporosis / Ca Disorders Flashcards
Does Ca carbonate need to be taken with food?
Yes
Does Ca citrate need to be taken with food?
No
CaSR agonist
Name of drug
Use
Cinacalcet
Suppresses abnormally high PTH
Used for parathyroid carcinoma and secondary hyperparathyroidism due to ESRD / HD.
PTH-independent Ca handling in kidney
- 65% of Ca is passively resorbed in proximal tubule. Paracellular.
- Uptake in thick ascending limb driven by V-gradient created by Na/K/Cl reabsorption.
- High Ca levels sensed by renal CaSR → inhibition of Na/K/Cl channel → inhibits Ca reabsorption
PTH-dependent Ca handling in kidney
Na/Cl cotransporter triggers opening of Ca channel in distal convoluted tubule
Effects of loop diuretics (furosemide) and thiazide diuretics on Ca
- Loop diuretics (furosemide) blocks Na/K/Cl transport. Used to treat hypercalcemia. Only use in pxs w/ adequate volume expansion
- Thiazide diuretics are used to treat hypercalciuria (too much Ca in urine). Blocks the Na/Cl cotransporter in the DCT → opening of V-gated Ca channel → Ca resorption. Work at the same place as PTH.
Treating hypocalcemia due to hypoparathyroidism
Give Ca and calcitriol.
Effects of E2 and PTH on bone
Increases growth / maturation of osteoblasts and decreases apoptosis.
E2 effect on OPG and osteoclasts
Upregulates OPG and osteoclast apoptosis.
Effects of E2 and PTH on RANKL
RANKL is increased by PTH, decreased by E2
Efficacy of raloxifene Adverse rxns (2)
Good at decreasing risk of vertebral fracture, but not effect on hip or other fracures.
Adverse rxns - hot flashes and risk of thrombosus.
4 bisphosphonates
Efficacy of each
Side effects (4)
- Alendronate – decreases risk of fracture by 50%
- Risedronate – same as alendronate
- Ibandronate – only useful for vertebral fractures. Not recommended.
- Zoledronic acid – Most potent. Reduces fractures by 70%. 1/3 of pxs have an acute phase rx w/ 1st infusion (fever / myalgias).
- Side effects
- Heartburn – important to take on empty stomach, drink 8 oz water, and remain upright for 30 min.
- Osteonecrosis of the jaw
- Atypical femoral fractures
Denosumab
Type of drug
Mechanism
Monoclonal Ab to RANKL (similar to OPG).
Decreases activation of osteoclasts.
Only anabolic drug Name Mechanism Efficacy Requirement Side effects
- Teriparatide
- Short-acting recombinant PTH analog
- Increases BMD by 10%. Decreases fractures by >50%.
- Requirement: Bone gains are quickly lost when drug is stopped, so antiresorptive agent must be used to “seal in” the gains.
- Side effects – nausea, dizziness, weakness